Detalles de la búsqueda
1.
Neoadjuvant chemotherapy for advanced oral cavity cancer.
CA Cancer J Clin
; 74(3): 213-223, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329372
2.
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
Cancer Immunol Immunother
; 73(4): 70, 2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430375
3.
Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.
Br J Cancer
; 127(8): 1497-1506, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945244
4.
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors.
Cancer
; 127(24): 4565-4573, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34547103
5.
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
Cancer
; 126(14): 3237-3243, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32365226
6.
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Cancer
; 126(10): 2146-2152, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32073648
7.
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
Cancer
; 130(6): 846-847, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236709
8.
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.
Br J Cancer
; 119(2): 153-159, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955135
9.
Reply to "Guarantee-time bias in studies on the relationship between immune-related adverse events and antitumor activity".
Cancer
; 128(13): 2551-2552, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35452138
10.
Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.
Oncologist
; 22(6): 680-693, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28507203
11.
Are taxanes the future for head and neck cancer? Pragmatism in the immunotherapy era.
Lancet Oncol
; 22(4): 413-415, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33684371
12.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Lancet Oncol
; 17(7): 956-965, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27247226
13.
Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
Cancer
; 122(24): 3803-3811, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27525588
14.
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
Laryngoscope
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38525973
15.
Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
Laryngoscope
; 134(2): 577-581, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470254
16.
Allergy History and Immunotherapy Response in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Otolaryngol Head Neck Surg
; 170(3): 828-836, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123496
17.
International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers.
Head Neck
; 46(6): 1253-1262, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600434
18.
Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.
Oncologist
; 18(8): 965-70, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23900000
19.
Single sample expression-anchored mechanisms predict survival in head and neck cancer.
PLoS Comput Biol
; 8(1): e1002350, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22291585
20.
The role of macrophages in the tumor microenvironment and tumor metabolism.
Semin Immunopathol
; 45(2): 187-201, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37002376